Axovant Sciences (AXON) Tops Q4 EPS by 4c; Raises Outlook
Get Alerts AXON Hot Sheet
Join SI Premium – FREE
Axovant Sciences (NASDAQ: AXON) reported Q4 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $226 million versus the consensus estimate of $180.96 million.
GUIDANCE:
Axovant Sciences sees FY2021 revenue of $740-780 million, versus the consensus of $742.24 million.
For earnings history and earnings-related data on Axovant Sciences (AXON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share